387 related articles for article (PubMed ID: 33216179)
1. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
[TBL] [Abstract][Full Text] [Related]
2. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
[TBL] [Abstract][Full Text] [Related]
3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
5. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
[TBL] [Abstract][Full Text] [Related]
6. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
Hanberg JS; Tang WHW; Wilson FP; Coca SG; Ahmad T; Brisco MA; Testani JM
Int J Cardiol; 2017 Aug; 241():277-282. PubMed ID: 28392080
[TBL] [Abstract][Full Text] [Related]
7. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
[TBL] [Abstract][Full Text] [Related]
8. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
[TBL] [Abstract][Full Text] [Related]
9. Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
Verbrugge FH; Martens P; Boonen L; Nijst P; Verhaert D; Noyens P; De Vusser P; Dupont M; Tang WHW; Mullens W
Acta Cardiol; 2018 Aug; 73(4):335-341. PubMed ID: 28971753
[TBL] [Abstract][Full Text] [Related]
10. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure.
Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L
ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739
[TBL] [Abstract][Full Text] [Related]
11. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
[TBL] [Abstract][Full Text] [Related]
12. Lung ultrasound and diuretic therapy in chronic heart failure: a randomised trial.
Cruz M; Ferreira JP; Diaz SO; Ferrão D; Ferreira AI; Girerd N; Sampaio F; Pimenta J
Clin Res Cardiol; 2024 Mar; 113(3):425-432. PubMed ID: 37289237
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
[TBL] [Abstract][Full Text] [Related]
14. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
[TBL] [Abstract][Full Text] [Related]
15. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial.
Simonavičius J; Sanders van-Wijk S; Rickenbacher P; Maeder MT; Pfister O; Kaufmann BA; Pfisterer M; Čelutkienė J; Puronaitė R; Knackstedt C; van Empel V; Brunner-La Rocca HP
Am J Med; 2019 Sep; 132(9):e679-e692. PubMed ID: 31051151
[TBL] [Abstract][Full Text] [Related]
17. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
[TBL] [Abstract][Full Text] [Related]
18. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
[TBL] [Abstract][Full Text] [Related]
19. Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.
Yilmaz MB; Gayat E; Salem R; Lassus J; Nikolaou M; Laribi S; Parissis J; Follath F; Peacock WF; Mebazaa A
Eur J Heart Fail; 2011 Nov; 13(11):1244-52. PubMed ID: 22024466
[TBL] [Abstract][Full Text] [Related]
20. Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
Palazzuoli A; Testani JM; Ruocco G; Pellegrini M; Ronco C; Nuti R
Int J Cardiol; 2016 Dec; 224():213-219. PubMed ID: 27657476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
